CHU Bordeaux Hopital Haut-Levaque

Pessac 33604

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Disease, Hodgkin

Studies at this site

• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early